or
forgot password
  • cancer clinical trials in pinehurst, NC

  • Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
    Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Breast Cancer
    Surgery in Treating Patients With Prostate Cancer
    Comprehensive Cancer Center at Moore Regional Hospital
    Pinehurst, North Carolina 28374
    Prostate Cancer
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Breast Cancer
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Esophageal Cancer, Gastric Cancer
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Breast Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Endometrial Cancer
    Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Comprehensive Cancer Center at Moore Regional Hospital
    Pinehurst, North Carolina 28374
    Lung Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Breast Cancer
    Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Cervical Cancer, Precancerous Condition
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Pinehurst, North Carolina 28374
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Colorectal Cancer
    Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Hereditary Breast/Ovarian Cancer (brca1, brca2), Osteoporosis, Ovarian Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Pinehurst, North Carolina 28374
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Pinehurst, North Carolina 28374
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Pinehurst, North Carolina 28374
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Pinehurst, North Carolina 28374
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Pinehurst, North Carolina 28374
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Using the Internet to Collect Symptoms and the Ability to Carry Out Daily Activities From Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Prostate Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Pinehurst, North Carolina 28374
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Ovarian Cancer
    Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Pinehurst, North Carolina 28374
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Pinehurst, North Carolina 28374
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Endometrial Cancer, Precancerous Condition
    High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Lung Cancer, Radiation Toxicity
    Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Lung Cancer
    Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Pinehurst, North Carolina 28374
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Pinehurst, North Carolina 28374
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Pinehurst, North Carolina 28374
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Studying Biomarkers in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Pinehurst, North Carolina 28374
    Atypical Endocervical Glandular Cell of Undetermined Significance, Atypical Endometrial Hyperplasia, Atypical Glandular Cell of Undetermined Significance, Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 2, Cervical Intraepithelial Neoplasia Grade 3, Human Papilloma Virus Infection
    Collecting Tumor Samples From Patients With Gynecological Tumors
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Pinehurst, North Carolina 28374
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Depression Screening in Patients Undergoing Radiation Therapy For Cancer
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Depression, Unspecified Adult Solid Tumor, Protocol Specific
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Melanoma (Skin)
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Colorectal Cancer, Precancerous Condition
    Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Lung Cancer
    BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
    First Health of the Carolinas
    Pinehurst, North Carolina 28374
    Renal Cell Carcinoma
    Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Lung Cancer
    Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Pinehurst, North Carolina 28374
    Breast Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Kidney Cancer
    Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Colorectal Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Pinehurst, North Carolina 28374
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Dysphagia, Lung Cancer, Pain, Esophagitis
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Pinehurst, North Carolina 28374
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Breast Cancer, Depression, Fatigue, Sleep Disorders
    Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Head and Neck Cancer, Precancerous Condition
    Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Prostate Cancer
    S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Pinehurst, North Carolina 28374
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Secondary Myelodysplastic Syndromes
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Pinehurst, North Carolina 28374
    Breast Cancer
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Pinehurst, North Carolina 28374
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
    FirstHealth Moore Regional Hospital
    Pinehurst, North Carolina 28374
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    S9630, Medroxyprogesterone in Treating Women With Breast Cancer
    FirstHealth Moore Regional Hospital
    Pinehurst, North Carolina 28374
    Breast Cancer, Endometrial Cancer
    Docetaxel in Treating Patients With Solid Tumors
    FirstHealth Moore Regional Hospital
    Pinehurst, North Carolina 28374
    Bladder Cancer, Breast Cancer, Head and Neck Cancer, Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Thoracoscopy in Patients With Stage IIIA Non-Small Cell Lung Cancer
    FirstHealth Moore Regional Hospital
    Pinehurst, North Carolina 28374
    Lung Cancer
    Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
    FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Ovarian Cancer
    Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
    FirstHealth Moore Regional Hospital
    Pinehurst, North Carolina 28374
    Leukemia
    Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
    Comprehensive Cancer Center at Moore Regional Hospital
    Pinehurst, North Carolina 28374
    Lymphoma
    Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
    FirstHealth Moore Regional Hospital
    Pinehurst, North Carolina 28374
    Anxiety Disorder, Depression, Fatigue, Lung Cancer
    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
    FirstHealth Moore Regional Hospital
    Pinehurst, North Carolina 28374
    Lymphoma
    Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas
    FirstHealth Moore Regional Hospital
    Pinehurst, North Carolina 28374
    Pancreatic Cancer
    Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
    FirstHealth Moore Regional Hospital
    Pinehurst, North Carolina 28374
    Lymphoma
    Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
    Moore Regional Community Hospital Comprehensive Cancer Center
    Pinehurst, North Carolina 28374
    Breast Cancer, Osteoporosis